Anti-platelet therapy: phosphodiesterase inhibitors-Reference-Cited by-同舟云学术

Anti-platelet therapy: phosphodiesterase inhibitors

Published:2011-09-09 Issue:4 Volume:72 Page:634-646
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gresele Paolo,Momi Stefania,Falcinelli Emanuela

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.04034.x/fullpdf

Reference119 articles.

1. Platelet signalling: cAMP and cGMP

2. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol Rev,2006

3. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase;Grant;Biochemistry,1984

4. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP;Maurice;Mol Pharmacol,1990

5. Human blood platelet 3′:5′-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase;Hidaka;Biochim Biophys Acta,1976

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelets in Thrombosis and Atherosclerosis;The American Journal of Pathology;2024-09

2. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11

3. The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke;Expert Opinion on Pharmacotherapy;2024-07-02

4. Enzyme Inhibition in Managing Cardiovascular Diseases;Current Enzyme Inhibition;2024-07

5. Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner;Cells;2024-06-26